Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,488.9
-24.0 (-0.96%)

 

  • STI Straits Times Index
    2,488.9
    -24.0 (-0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.7
    -6.6 (-0.44%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,708.8
    -78.4 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,269.2
    14.9 (0.46%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,418.5
    -67.3 (-0.29%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,144.0
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.9M
  • Value: 883.4M
  • Rise: 100
  • Fall: 182
  • Unch: 496

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.084+0.002
Rex Intl0.147+0.016
Aspen0.255-0.020
Sembcorp Marine0.129-
Intl Cement0.063+0.001
ThaiBev0.580-0.005
Genting Sing0.665-0.010
Sembcorp Ind1.630+0.090
CapitaMall Trust1.820-
Guoan Intl0.023+0.004

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 28 Oct 2020 17:04
Last (SGD): 0.300 Change: -0.005 High: 0.315 Remarks: -
Change (%): -1.64 Low: 0.300
Open 0.315 Yesterday's Close 0.305
Buy Price 0.300 Sell Price 0.310
Buy Volume ('000) 383.8 Sell Volume ('000) 265.0
Cumulative Volume ('000) 500.8 Cumulative Value 152,943
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01822 Trailing EPS (SGD) e -0.01197 NAV (SGD) b 0.0408
PE a - Trailing PE f - Price / NAV b 7.3529
Dividend (SGD) d - Cash In Hand (SGD) g 0.0329 Issued & Paid-up Shares c 264,047,000
Dividend Yield (%) d - Price / Cash In Hand g 9.119 Treasury Shares h -
Beta - 75 Daysi -0.176 R-Squared - 75 Days(%)i 0.09 Market Cap (M) 79.214
Beta - 500 Daysi 0.452 R-Squared - 500 Days (%)i 0.88 Enterprise Value (M) 74.109
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 72.9085 6-Month VWAP 0.412 Free Float (%) 34.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 79.214 - - 7.3529 -
Industry Medical & Biotechnology SGX 905.455 21.542 20.796 1.2894 2.120
Medical Specialties SGX 4,126.446 40.361 36.965 13.1486 1.270
Index FTSE ST Catalist Index SGX 64.361 30.063 88.683 1.1077 1.721
Local Peer Top Glove SGX 23,209.896 38.229 38.228 14.2714 1.349
Local Peer Medtecs Intl SGX 620.834 396.491 11.242 4.3952 -
Local Peer UGHealthcare SGX 550.406 41.074 41.069 7.7155 0.254
Local Peer Yunnan Energy SGX 35.531 - - 0.7346 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 193,561.698 52.371 39.672 6.0823 0.157
Global Peer ABBOTT LABORATORIES NYSE 192,244.147 52.440 57.369 - 1.210
Global Peer DANAHER CORP NYSE 170,334.197 68.440 54.680 4.9097 0.278
Global Peer MEDTRONIC PLC NYSE 141,445.376 29.535 32.059 2.8123 2.124
Global Peer INTUITIVE SURGICAL INC NASDAQ 84,745.399 61.441 80.472 9.1539 -
Global Peer STRYKER CORP NYSE 80,176.857 38.491 50.079 6.2864 0.997
Global Peer BECTON DICKINSON & CO NYSE 70,797.605 65.432 91.470 2.9474 1.184
Global Peer BOSTON SCIENTIFIC CORP NYSE 51,575.654 10.974 12.959 3.3027 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,678.472 45.542 59.896 11.3243 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 44,869.360 34.352 40.271 3.6477 1.857
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), TOPGLOV (Bursa), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), INSULET CORPORATION (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), HARTA (Bursa), PERKINELMER INC (NYSE), WATERS CORP (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), ABIOMED INC (NASDAQ), NOVOCURE LTD (NASDAQ), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), DENTSPLY SIRONA INC (NASDAQ), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), BRUKER CORPORATION (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), HAEMONETICS CORP (NYSE), NEVRO CORP (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), KANGJI MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), GLAUKOS CORPORATION (NYSE), AK MEDICAL (HKEx), LIVANOVA PLC (NASDAQ), NUVASIVE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CONMED CORP (NYSE), PEIJIA-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), OUTSET MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ATRICURE INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), PULMONX CORPORATION (NASDAQ), MESA LABORATORIES INC (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), ORASURE TECHNOLOGIES INC (NASDAQ), CIRC (HKEx), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), KDL MEDICAL (HKEx), CERUS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), VERICEL CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), VAPOTHERM INC (NYSE), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SI BONE INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), PW MEDTECH (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), INVACARE CORP (NYSE), REPRO MEDSYSTEMS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), STEREOTAXIS INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), DERMTECH INC (NASDAQ), TELA BIO INC (NASDAQ), SIENTRA INC (NASDAQ), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLITON INC (NASDAQ), MODERN DENTAL (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VINCENT MED (HKEx), SURGALIGN HOLDINGS INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), INTRICOM CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), LKL (Bursa), NEURONETICS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), PAVMED INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), RESPIRI LTD (ASX), ELECTROMED INC (NYSE American), ELECTROCORE INC (NASDAQ), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPHROS INC (NASDAQ), BIOMERICA INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), LIANLUO SMART LIMITED (NASDAQ), CONFORMIS INC (NASDAQ), DAXOR CORP (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TITAN MEDICAL INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), MICRO-X LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), STRATA SKIN SCIENCES INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), OPTISCAN IMAGING (ASX), APPLIED UV INC (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), KELFRED (HKEx), DIMERIX LTD (ASX), IMMUCELL CORP (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), LIFE HEALTH-NEW (HKEx), IRIDEX CORP (NASDAQ), CARDIEX LTD (ASX), OVENTUS MEDICAL LTD (ASX), NEUROTROPE INC (NASDAQ), BIOLASE INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), METALICITY LIMITED (ASX), REWALK ROBOTICS LTD (NASDAQ), AVINGER INC (NASDAQ), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), USCOM LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CYANOTECH CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), CHECK-CAP LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), DIGIRAD CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), ADHERIUM LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DYNATRONICS CORP (NASDAQ), CANCER GENETICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ANALYTICA (ASX), DORSAVI LTD (ASX), OBALON THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), NEUROMETRIX INC (NASDAQ), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.015
-4.76 %
10 Days --0.040
-11.76 %
20 Days --0.040
-11.76 %
Medium Term Return 3 Months --0.135
-31.03 %
6 Months --0.140
-31.82 %
1 Year -+0.065
+27.66 %
Annualised Return Annualised --
+27.66 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.175 - 0.885 Change From 1 Year Low +0.125 % Change From 1 Year Low (%) +71.43
Change From 1 Year High -0.585 % Change From 1 Year High (%) -66.10
2 Years Range 0.175 - 0.885 Change From 2 Years Low +0.125 % Change From 2 Years Low (%) +71.43
Change From 2 Years High -0.585 % Change From 2 Years High (%) -66.10
5 Years Range 0.175 - 0.885 Change From 5 Years Low +0.125 % Change From 5 Years Low (%) +71.43
Change From 5 Years High -0.585 % Change From 5 Years High (%) -66.10
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) +7.14 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
27 Oct 2020 0.310 0.315 0.305 0.305 1,146,900 0.3122
26 Oct 2020 0.315 0.315 0.300 0.310 711,000 0.3050
23 Oct 2020 0.315 0.320 0.310 0.315 581,600 0.3118
22 Oct 2020 0.320 0.320 0.310 0.315 1,604,300 0.3147
21 Oct 2020 0.325 0.330 0.315 0.315 1,495,700 0.3214
20 Oct 2020 0.325 0.330 0.315 0.315 1,476,900 0.3194
19 Oct 2020 0.325 0.335 0.325 0.325 1,152,100 0.3270
16 Oct 2020 0.330 0.335 0.325 0.325 642,000 0.3275
15 Oct 2020 0.330 0.340 0.320 0.325 1,034,300 0.3299
14 Oct 2020 0.345 0.350 0.330 0.330 3,471,100 0.3401
13 Oct 2020 0.330 0.345 0.330 0.340 3,813,600 0.3374
12 Oct 2020 0.325 0.335 0.325 0.330 2,639,900 0.3282
09 Oct 2020 0.325 0.335 0.320 0.320 3,096,000 0.3266
08 Oct 2020 0.325 0.335 0.320 0.325 2,643,200 0.3250
07 Oct 2020 0.315 0.335 0.315 0.320 2,332,300 0.3251
06 Oct 2020 0.325 0.325 0.315 0.315 1,196,000 0.3202
05 Oct 2020 0.320 0.335 0.310 0.325 4,878,500 0.3236
02 Oct 2020 0.325 0.325 0.315 0.320 1,578,400 0.3184
01 Oct 2020 0.320 0.335 0.315 0.320 3,787,700 0.3235
30 Sep 2020 0.340 0.340 0.310 0.315 3,787,900 0.3225
29 Sep 2020 0.340 0.360 0.340 0.340 1,736,300 0.3464
28 Sep 2020 0.365 0.365 0.335 0.340 1,690,700 0.3444
Summary
Current 2 Weeks
(14 Oct 2020 to 27 Oct 2020)
0.345 0.350 0.300 0.305 13,315,900 -
Previous 2 Weeks
(30 Sep 2020 to 13 Oct 2020)
0.340 0.350 0.300 0.340 29,753,500 -
4 Weeks from
(02 Sep 2020 to 29 Sep 2020)
0.375 0.375 0.300 0.340 68,523,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.